• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

深度转录组分析描绘了VEXAS综合征患者功能失调的免疫反应图景。

In depth transcriptomic profiling defines a landscape of dysfunctional immune responses in patients with VEXAS syndrome.

作者信息

Mizumaki Hiroki, Gao Shouguo, Wu Zhijie, Gutierrez-Rodrigues Fernanda, Bissa Massimiliano, Feng Xingmin, Groarke Emma M, Li Haoran, Alemu Lemlem, Raffo Diego Quinones, Darden Ivana, Kajigaya Sachiko, Grayson Peter C, Franchini Genoveffa, Young Neal S, Patel Bhavisha A

机构信息

Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.

Animal Models and Retroviral Vaccines Section, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

出版信息

Nat Commun. 2025 May 20;16(1):4690. doi: 10.1038/s41467-025-59890-0.

DOI:10.1038/s41467-025-59890-0
PMID:40394087
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12092610/
Abstract

VEXAS (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) syndrome is caused by inactivating somatic mutations in the UBA1 gene. Here, we characterize the immunological landscape of VEXAS syndrome by performing multi-omics single-cell RNA analysis, cytokine multiplex assays, and in vitro functional assays on patients' peripheral blood. Our data reveals a broad immune system activation with upregulation of multiple inflammatory response pathways and proinflammatory cytokines. Unexpectedly, we find that monocytes have dysfunctional features irrespective of UBA1 mutation status, exhibiting impaired efferocytosis and blunted cytokine production in vitro. In contrast, UBA1-mutated NK cells show an upregulation of the inflammation pathways and enhanced cytotoxicity. Within the lymphocyte subsets, predominantly UBA1 wild-type, we identify clonal expansion of effector memory CD8 T cells and skewed B cell differentiation with loss of transitional B cells and expansion of plasmablasts. Thus, our analysis indicates that VEXAS syndrome is characterized by profound alterations in both adaptive and innate immune systems, accounting for the complex pathophysiology of the disease, and provides a basis to understand the marked clinical heterogeneity and variable disease course.

摘要

VEXAS(空泡、E1酶、X连锁、自身炎症、体细胞)综合征由UBA1基因的体细胞失活突变引起。在此,我们通过对患者外周血进行多组学单细胞RNA分析、细胞因子多重检测和体外功能检测,对VEXAS综合征的免疫格局进行了表征。我们的数据揭示了广泛的免疫系统激活,多种炎症反应途径和促炎细胞因子上调。出乎意料的是,我们发现单核细胞具有功能障碍特征,与UBA1突变状态无关,在体外表现出吞噬功能受损和细胞因子产生减弱。相比之下,UBA1突变的自然杀伤细胞显示炎症途径上调和细胞毒性增强。在主要为UBA1野生型的淋巴细胞亚群中,我们鉴定出效应记忆CD8 T细胞的克隆扩增以及B细胞分化偏向,伴有过渡性B细胞丢失和成浆细胞扩增。因此,我们的分析表明,VEXAS综合征的特征是适应性和先天性免疫系统均发生深刻改变,这解释了该疾病复杂的病理生理学,并为理解显著的临床异质性和可变的病程提供了基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53b6/12092610/d2fbd815b006/41467_2025_59890_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53b6/12092610/1d3729c2b134/41467_2025_59890_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53b6/12092610/6b3b8b6c1ce3/41467_2025_59890_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53b6/12092610/79f87bc973d9/41467_2025_59890_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53b6/12092610/4d11bba9e2e9/41467_2025_59890_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53b6/12092610/ba466865184f/41467_2025_59890_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53b6/12092610/d2fbd815b006/41467_2025_59890_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53b6/12092610/1d3729c2b134/41467_2025_59890_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53b6/12092610/6b3b8b6c1ce3/41467_2025_59890_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53b6/12092610/79f87bc973d9/41467_2025_59890_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53b6/12092610/4d11bba9e2e9/41467_2025_59890_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53b6/12092610/ba466865184f/41467_2025_59890_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53b6/12092610/d2fbd815b006/41467_2025_59890_Fig6_HTML.jpg

相似文献

1
In depth transcriptomic profiling defines a landscape of dysfunctional immune responses in patients with VEXAS syndrome.深度转录组分析描绘了VEXAS综合征患者功能失调的免疫反应图景。
Nat Commun. 2025 May 20;16(1):4690. doi: 10.1038/s41467-025-59890-0.
2
Somatic Mutations in and Severe Adult-Onset Autoinflammatory Disease.和严重成人发病的自身炎症性疾病中的体细胞突变。
N Engl J Med. 2020 Dec 31;383(27):2628-2638. doi: 10.1056/NEJMoa2026834. Epub 2020 Oct 27.
3
Inflammatory Signatures in VEXAS Syndrome, Myelodysplasia Cutis, and Sweet Syndrome.VEXAS综合征、骨髓发育异常相关性皮肤病变和Sweet综合征中的炎症特征。
JAMA Dermatol. 2025 May 1;161(5):538-543. doi: 10.1001/jamadermatol.2025.0034.
4
Methodology and clinical utility of longitudinal UBA1 tracking in VEXAS syndrome.VEXAS综合征中纵向UBA1追踪的方法学及临床应用价值
Br J Haematol. 2025 Jan;206(1):331-336. doi: 10.1111/bjh.19897. Epub 2024 Nov 13.
5
Is it VEXAS or is it vasculitis?是VEXAS综合征还是血管炎?
Clin Exp Rheumatol. 2025 Apr;43(4):749-755. doi: 10.55563/clinexprheumatol/zfpryq. Epub 2025 Mar 25.
6
Estimated Prevalence and Clinical Manifestations of UBA1 Variants Associated With VEXAS Syndrome in a Clinical Population.在临床人群中与 VEXAS 综合征相关的 UBA1 变异体的估计患病率和临床表现。
JAMA. 2023 Jan 24;329(4):318-324. doi: 10.1001/jama.2022.24836.
7
UBA1 and DNMT3A mutations in VEXAS syndrome. A case report and literature review.VEXAS综合征中的UBA1和DNMT3A突变:一例报告及文献综述
Mod Rheumatol Case Rep. 2022 Jan 7;6(1):134-139. doi: 10.1093/mrcr/rxab021.
8
Azacitidine for patients with Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic syndrome (VEXAS) and myelodysplastic syndrome: data from the French VEXAS registry.阿扎胞苷治疗空泡酶、E1 酶、X 连锁、自身炎症、体细胞综合征(VEXAS)和骨髓增生异常综合征患者:来自法国 VEXAS 登记处的数据。
Br J Haematol. 2022 Feb;196(4):969-974. doi: 10.1111/bjh.17893. Epub 2021 Oct 14.
9
Description of a novel splice site variant in UBA1 gene causing VEXAS syndrome.描述 UBA1 基因中一种新型剪接位点变异导致 VEXAS 综合征。
Rheumatology (Oxford). 2024 Oct 1;63(10):2897-2902. doi: 10.1093/rheumatology/keae201.
10
[VEXAS syndrome - a chameleon of inflammatory syndromes].[VEXAS综合征——一种炎症综合征的“变色龙”]
Praxis (Bern 1994). 2025 Feb;114(2):75-79. doi: 10.23785/PRAXIS.2025.02.009.

引用本文的文献

1
VEXAS Syndrome: Genetics, Gender Differences, Clinical Insights, Diagnostic Pitfalls, and Emerging Therapies.VEXAS综合征:遗传学、性别差异、临床见解、诊断陷阱及新兴疗法
Int J Mol Sci. 2025 Aug 17;26(16):7931. doi: 10.3390/ijms26167931.
2
Prevalence and outcome of VEXAS syndrome in unrelated hematopoietic cell transplantation for bone marrow failure.骨髓衰竭非亲缘造血细胞移植中VEXAS综合征的患病率及结局
Clin Exp Med. 2025 Aug 22;25(1):300. doi: 10.1007/s10238-025-01832-7.

本文引用的文献

1
Long-term genetic and clinical remissions after cessation of azacitidine treatment in patients with VEXAS syndrome.维克斯综合征(VEXAS syndrome)患者停用阿扎胞苷治疗后的长期基因缓解和临床缓解
Hemasphere. 2024 Jul 30;8(8):e129. doi: 10.1002/hem3.129. eCollection 2024 Aug.
2
Opportunistic Infections, Mortality Risk, and Prevention Strategies in Patients With Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic (VEXAS) Syndrome.空泡、E1酶、X连锁、自身炎症性、体细胞(VEXAS)综合征患者的机会性感染、死亡风险及预防策略
Open Forum Infect Dis. 2024 Jul 23;11(7):ofae405. doi: 10.1093/ofid/ofae405. eCollection 2024 Jul.
3
De-escalation of corticosteroids and clonal remission in mutation-driven VEXAS syndrome with 5-azacytidine.
在由突变驱动的VEXAS综合征中使用5-氮杂胞苷使皮质类固醇减量与克隆缓解
Haematologica. 2024 Oct 1;109(10):3431-3434. doi: 10.3324/haematol.2024.285519.
4
Skin Manifestations of VEXAS Syndrome and Associated Genotypes.VEXAS 综合征的皮肤表现及相关基因型。
JAMA Dermatol. 2024 Aug 1;160(8):822-829. doi: 10.1001/jamadermatol.2024.1657.
5
Efficacy and safety of targeted therapies in VEXAS syndrome: retrospective study from the FRENVEX.靶向治疗在 VEXAS 综合征中的疗效和安全性:来自 FRENVEX 的回顾性研究。
Ann Rheum Dis. 2024 Sep 30;83(10):1358-1367. doi: 10.1136/ard-2024-225640.
6
Molecular and clinical presentation of UBA1-mutated myelodysplastic syndromes.UBA1 突变型骨髓增生异常综合征的分子和临床特征。
Blood. 2024 Sep 12;144(11):1221-1229. doi: 10.1182/blood.2023023723.
7
Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry.VEXAS 综合征中眼眶/眼部炎症受累:来自国际 AIDA 网络 VEXAS 登记处的数据。
Semin Arthritis Rheum. 2024 Jun;66:152430. doi: 10.1016/j.semarthrit.2024.152430. Epub 2024 Mar 18.
8
Comparing clinical features between males and females with VEXAS syndrome: data from literature analysis of patient reports.比较 VEXAS 综合征男性和女性患者的临床特征:来自患者报告文献分析的数据。
Rheumatology (Oxford). 2024 Oct 1;63(10):2694-2700. doi: 10.1093/rheumatology/keae123.
9
Susceptibility to mycobacterial infection in VEXAS syndrome.VEXAS综合征中对分枝杆菌感染的易感性。
Rheumatology (Oxford). 2025 Feb 1;64(2):831-835. doi: 10.1093/rheumatology/keae087.
10
Venous and arterial thrombosis in patients with VEXAS syndrome.VEXAS 综合征患者的静脉和动脉血栓形成。
Blood. 2024 May 23;143(21):2190-2200. doi: 10.1182/blood.2023022329.